1	2	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Brief	_	_	JJ	_	_	_	_	_


1	Overview	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	Established	_	_	VBN	_	_	_	_	_
5	Practice	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	Determining	_	_	VBG	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	Amino	_	_	JJ	_	_	_	_	_
10	Acid	_	_	NN	_	_	_	_	_
11	Composition	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	CHO	_	_	NN	_	_	_	_	_
15	Cell	_	_	NN	_	_	_	_	_
16	Medium	_	_	NN	_	_	_	_	_


1	Reports	_	_	NNS	_	_	_	_	_
2	on	_	_	IN	_	_	_	_	_
3	improving	_	_	VBG	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	culture	_	_	NN	_	_	_	_	_
6	medium	_	_	NN	_	_	_	_	_
7	composition	_	_	NN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	CHO	_	_	NNP	_	_	_	_	_
10	cells	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	specifically	_	_	RB	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	relation	_	_	NN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	amino	_	_	JJ	_	_	_	_	_
18	acids	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	are	_	_	VBP	_	_	_	_	_
21	relatively	_	_	RB	_	_	_	_	_
22	limited	_	_	VBN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	number	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	paucity	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	reports	_	_	NNS	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	strikingly	_	_	RB	_	_	_	_	_
7	unusual	_	_	JJ	_	_	_	_	_
8	especially	_	_	RB	_	_	_	_	_
9	considering	_	_	VBG	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	widespread	_	_	JJ	_	_	_	_	_
12	use	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	vast	_	_	JJ	_	_	_	_	_
15	economic	_	_	JJ	_	_	_	_	_
16	importance	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	CHO	_	_	NNP	_	_	_	_	_
19	cells	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	2.1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Statistical	_	_	JJ	_	_	_	_	_
2	Methods	_	_	NNS	_	_	_	_	_
3	:	_	_	:	_	_	_	_	_
4	Utilizing	_	_	VBG	_	_	_	_	_
5	Data-Driven	_	_	JJ	_	_	_	_	_
6	Models	_	_	NNS	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	Experimental	_	_	JJ	_	_	_	_	_
9	Design	_	_	NN	_	_	_	_	_


1	Statistical	_	_	JJ	_	_	_	_	_
2	design	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	also	_	_	RB	_	_	_	_	_
5	known	_	_	VBN	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	design-of-experiments	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	arguably	_	_	RB	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	most	_	_	RBS	_	_	_	_	_
13	commonly	_	_	RB	_	_	_	_	_
14	employed	_	_	VBN	_	_	_	_	_
15	strategy	_	_	NN	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	medium	_	_	JJ	_	_	_	_	_
18	development	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Unfortunately	_	_	RB	_	_	_	_	_
2	most	_	_	RBS	_	_	_	_	_
3	such	_	_	JJ	_	_	_	_	_
4	studies	_	_	NNS	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	CHO	_	_	NNP	_	_	_	_	_
7	cells	_	_	NNS	_	_	_	_	_
8	focus	_	_	VBP	_	_	_	_	_
9	on	_	_	IN	_	_	_	_	_
10	components	_	_	NNS	_	_	_	_	_
11	such	_	_	JJ	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	those	_	_	DT	_	_	_	_	_
14	relevant	_	_	JJ	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	carbon	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	energy	_	_	NN	_	_	_	_	_
20	metabolism	_	_	NN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	only	_	_	RB	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	limited	_	_	JJ	_	_	_	_	_
25	number	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	studies	_	_	NNS	_	_	_	_	_
28	specifically	_	_	RB	_	_	_	_	_
29	addressing	_	_	VBG	_	_	_	_	_
30	amino	_	_	JJ	_	_	_	_	_
31	acids	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	line	_	_	NN	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	observation	_	_	NN	_	_	_	_	_
6	for	_	_	IN	_	_	_	_	_
7	statistical	_	_	JJ	_	_	_	_	_
8	methodologies	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	search	_	_	NN	_	_	_	_	_
11	heuristics	_	_	NNS	_	_	_	_	_
12	such	_	_	JJ	_	_	_	_	_
13	as	_	_	IN	_	_	_	_	_
14	genetic	_	_	JJ	_	_	_	_	_
15	algorithms	_	_	NNS	_	_	_	_	_
16	commonly	_	_	RB	_	_	_	_	_
17	employed	_	_	VBN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	medium	_	_	JJ	_	_	_	_	_
20	development	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	optimization	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	various	_	_	JJ	_	_	_	_	_
25	organisms	_	_	NNS	_	_	_	_	_
26	have	_	_	VBP	_	_	_	_	_
27	not	_	_	RB	_	_	_	_	_
28	been	_	_	VBN	_	_	_	_	_
29	utilized	_	_	VBN	_	_	_	_	_
30	for	_	_	IN	_	_	_	_	_
31	improving	_	_	VBG	_	_	_	_	_
32	CHO	_	_	NNP	_	_	_	_	_
33	cell	_	_	NN	_	_	_	_	_
34	medium	_	_	NN	_	_	_	_	_
35	compositions	_	_	NNS	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	even	_	_	RB	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	chemically	_	_	RB	_	_	_	_	_
40	defined	_	_	VBN	_	_	_	_	_
41	cell-free	_	_	JJ	_	_	_	_	_
42	formulations	_	_	NNS	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	Low	_	_	JJ	_	_	_	_	_
2	glutamine	_	_	NN	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	high	_	_	JJ	_	_	_	_	_
5	essential	_	_	JJ	_	_	_	_	_
6	amino	_	_	NN	_	_	_	_	_
7	acid	_	_	NN	_	_	_	_	_
8	concentrations	_	_	NNS	_	_	_	_	_
9	led	_	_	VBD	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	high	_	_	JJ	_	_	_	_	_
12	mAb	_	_	NN	_	_	_	_	_
13	production	_	_	NN	_	_	_	_	_
14	against	_	_	IN	_	_	_	_	_
15	Botulinum	_	_	NNP	_	_	_	_	_
16	A	_	_	NNP	_	_	_	_	_
17	by	_	_	IN	_	_	_	_	_
18	CHO	_	_	NNP	_	_	_	_	_
19	cells	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	amino	_	_	NN	_	_	_	_	_
3	acid	_	_	NN	_	_	_	_	_
4	other	_	_	JJ	_	_	_	_	_
5	than	_	_	IN	_	_	_	_	_
6	glutamine	_	_	NN	_	_	_	_	_
7	(	_	_	-LRB-	_	_	_	_	_
8	analytically	_	_	RB	_	_	_	_	_
9	uncharacterized	_	_	JJ	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	was	_	_	VBD	_	_	_	_	_
12	identified	_	_	VBN	_	_	_	_	_
13	as	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	limiting	_	_	VBG	_	_	_	_	_
16	component	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	study	_	_	NN	_	_	_	_	_
20	that	_	_	WDT	_	_	_	_	_
21	employed	_	_	VBD	_	_	_	_	_
22	response	_	_	NN	_	_	_	_	_
23	surface	_	_	NN	_	_	_	_	_
24	methodology	_	_	NN	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	evaluate	_	_	VB	_	_	_	_	_
27	medium-associated	_	_	JJ	_	_	_	_	_
28	effects	_	_	NNS	_	_	_	_	_
29	on	_	_	IN	_	_	_	_	_
30	viable	_	_	JJ	_	_	_	_	_
31	cell	_	_	NN	_	_	_	_	_
32	density	_	_	NN	_	_	_	_	_
33	(	_	_	-LRB-	_	_	_	_	_
34	as	_	_	IN	_	_	_	_	_
35	a	_	_	DT	_	_	_	_	_
36	proxy	_	_	NN	_	_	_	_	_
37	for	_	_	IN	_	_	_	_	_
38	mAb	_	_	NN	_	_	_	_	_
39	concentration	_	_	NN	_	_	_	_	_
40	)	_	_	-RRB-	_	_	_	_	_
41	during	_	_	IN	_	_	_	_	_
42	coupled	_	_	VBN	_	_	_	_	_
43	production	_	_	NN	_	_	_	_	_
44	and	_	_	CC	_	_	_	_	_
45	growth	_	_	NN	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	Gonz√°lez	_	_	NNP	_	_	_	_	_
2	et	_	_	NNP	_	_	_	_	_
3	al.	_	_	FW	_	_	_	_	_
4	used	_	_	VBD	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	Plackett-Burman	_	_	NNP	_	_	_	_	_
7	design	_	_	NN	_	_	_	_	_
8	method	_	_	NN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	optimize	_	_	VB	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	contribution	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	ten	_	_	CD	_	_	_	_	_
15	amino	_	_	NN	_	_	_	_	_
16	acids	_	_	NNS	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	rate	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	growth	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	monoclonal	_	_	JJ	_	_	_	_	_
24	antibody	_	_	NN	_	_	_	_	_
25	production	_	_	NN	_	_	_	_	_
26	by	_	_	IN	_	_	_	_	_
27	Chinese	_	_	JJ	_	_	_	_	_
28	hamster	_	_	NN	_	_	_	_	_
29	ovary	_	_	NN	_	_	_	_	_
30	cells	_	_	NNS	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	10	_	_	CD	_	_	_	_	_
3	amino	_	_	NN	_	_	_	_	_
4	acids	_	_	NNS	_	_	_	_	_
5	were	_	_	VBD	_	_	_	_	_
6	specifically	_	_	RB	_	_	_	_	_
7	identified	_	_	VBN	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	per	_	_	IN	_	_	_	_	_
10	their	_	_	PRP$	_	_	_	_	_
11	superior	_	_	JJ	_	_	_	_	_
12	uptake	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	utilization	_	_	NN	_	_	_	_	_
15	by	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	CHO	_	_	NN	_	_	_	_	_
18	cell	_	_	NN	_	_	_	_	_
19	metabolism	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	analysis	_	_	NN	_	_	_	_	_
3	was	_	_	VBD	_	_	_	_	_
4	carried	_	_	VBN	_	_	_	_	_
5	out	_	_	RP	_	_	_	_	_
6	both	_	_	CC	_	_	_	_	_
7	during	_	_	IN	_	_	_	_	_
8	exponential	_	_	JJ	_	_	_	_	_
9	phase	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	growth	_	_	NN	_	_	_	_	_
12	through	_	_	IN	_	_	_	_	_
13	monitoring	_	_	VBG	_	_	_	_	_
14	how	_	_	WRB	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	specific	_	_	JJ	_	_	_	_	_
17	growth	_	_	NN	_	_	_	_	_
18	rate	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	concentration	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	viable	_	_	JJ	_	_	_	_	_
25	cell	_	_	NN	_	_	_	_	_
26	concentration	_	_	NN	_	_	_	_	_
27	evolved	_	_	VBD	_	_	_	_	_
28	over	_	_	IN	_	_	_	_	_
29	time	_	_	NN	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	during	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	phase	_	_	NN	_	_	_	_	_
35	where	_	_	WRB	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	cell	_	_	NN	_	_	_	_	_
38	population	_	_	NN	_	_	_	_	_
39	reached	_	_	VBD	_	_	_	_	_
40	a	_	_	DT	_	_	_	_	_
41	very	_	_	RB	_	_	_	_	_
42	high	_	_	JJ	_	_	_	_	_
43	density	_	_	NN	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	through	_	_	IN	_	_	_	_	_
46	monitoring	_	_	NN	_	_	_	_	_
47	of	_	_	IN	_	_	_	_	_
48	the	_	_	DT	_	_	_	_	_
49	final	_	_	JJ	_	_	_	_	_
50	monoclonal	_	_	JJ	_	_	_	_	_
51	antibody	_	_	NN	_	_	_	_	_
52	product	_	_	NN	_	_	_	_	_
53	concentration	_	_	NN	_	_	_	_	_
54	and	_	_	CC	_	_	_	_	_
55	the	_	_	DT	_	_	_	_	_
56	specific	_	_	JJ	_	_	_	_	_
57	productivity	_	_	NN	_	_	_	_	_
58	of	_	_	IN	_	_	_	_	_
59	the	_	_	DT	_	_	_	_	_
60	cell	_	_	NN	_	_	_	_	_
61	population	_	_	NN	_	_	_	_	_
62	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	investigation	_	_	NN	_	_	_	_	_
3	aimed	_	_	VBD	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	determine	_	_	VB	_	_	_	_	_
6	which	_	_	WDT	_	_	_	_	_
7	among	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	ten	_	_	CD	_	_	_	_	_
10	amino	_	_	JJ	_	_	_	_	_
11	acids	_	_	NNS	_	_	_	_	_
12	were	_	_	VBD	_	_	_	_	_
13	critical	_	_	JJ	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	supporting	_	_	VBG	_	_	_	_	_
16	health	_	_	NN	_	_	_	_	_
17	growth	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	population	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	product	_	_	NN	_	_	_	_	_
23	formation	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	return	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	information	_	_	NN	_	_	_	_	_
6	could	_	_	MD	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	utilized	_	_	VBN	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	designing	_	_	VBG	_	_	_	_	_
11	an	_	_	DT	_	_	_	_	_
12	amino	_	_	JJ	_	_	_	_	_
13	acid	_	_	NN	_	_	_	_	_
14	supplementation	_	_	NN	_	_	_	_	_
15	regime	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	through	_	_	IN	_	_	_	_	_
18	which	_	_	WDT	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	superior	_	_	JJ	_	_	_	_	_
21	culture	_	_	NN	_	_	_	_	_
22	could	_	_	MD	_	_	_	_	_
23	be	_	_	VB	_	_	_	_	_
24	achieved	_	_	VBN	_	_	_	_	_
25	through	_	_	IN	_	_	_	_	_
26	medium	_	_	JJ	_	_	_	_	_
27	improvements	_	_	NNS	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	authors	_	_	NNS	_	_	_	_	_
3	proposed	_	_	VBD	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	two-stage	_	_	JJ	_	_	_	_	_
6	strategy	_	_	NN	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	providing	_	_	VBG	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	cells	_	_	NNS	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	key	_	_	JJ	_	_	_	_	_
14	amino	_	_	JJ	_	_	_	_	_
15	acids	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	One	_	_	CD	_	_	_	_	_
2	stage	_	_	NN	_	_	_	_	_
3	focused	_	_	VBN	_	_	_	_	_
4	on	_	_	IN	_	_	_	_	_
5	achieving	_	_	VBG	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	healthy	_	_	JJ	_	_	_	_	_
8	cell	_	_	NN	_	_	_	_	_
9	culture	_	_	NN	_	_	_	_	_
10	through	_	_	IN	_	_	_	_	_
11	focusing	_	_	VBG	_	_	_	_	_
12	on	_	_	IN	_	_	_	_	_
13	growth	_	_	NN	_	_	_	_	_
14	optimization	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	second	_	_	JJ	_	_	_	_	_
19	stage	_	_	NN	_	_	_	_	_
20	which	_	_	WDT	_	_	_	_	_
21	optimizes	_	_	VBZ	_	_	_	_	_
22	product	_	_	NN	_	_	_	_	_
23	formation	_	_	NN	_	_	_	_	_
24	once	_	_	IN	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	large	_	_	JJ	_	_	_	_	_
27	cell	_	_	NN	_	_	_	_	_
28	population	_	_	NN	_	_	_	_	_
29	has	_	_	VBZ	_	_	_	_	_
30	been	_	_	VBN	_	_	_	_	_
31	achieved	_	_	VBN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	More	_	_	RBR	_	_	_	_	_
2	recently	_	_	RB	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	Torkashvand	_	_	NNP	_	_	_	_	_
5	et	_	_	FW	_	_	_	_	_
6	al.	_	_	FW	_	_	_	_	_
7	used	_	_	VBD	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	Plackett-Burman	_	_	NNP	_	_	_	_	_
10	design	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	screen	_	_	VB	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	effects	_	_	NNS	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	amino	_	_	JJ	_	_	_	_	_
17	acids	_	_	NNS	_	_	_	_	_
18	on	_	_	IN	_	_	_	_	_
19	promoting	_	_	VBG	_	_	_	_	_
20	growth	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	then	_	_	RB	_	_	_	_	_
24	optimized	_	_	VBD	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	medium	_	_	JJ	_	_	_	_	_
27	concentrations	_	_	NNS	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	combination	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	amino	_	_	NN	_	_	_	_	_
33	acids	_	_	NNS	_	_	_	_	_
34	using	_	_	VBG	_	_	_	_	_
35	response	_	_	NN	_	_	_	_	_
36	surface	_	_	NN	_	_	_	_	_
37	methodology	_	_	NN	_	_	_	_	_
38	to	_	_	TO	_	_	_	_	_
39	determine	_	_	VB	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	feed	_	_	NN	_	_	_	_	_
42	composition	_	_	NN	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	statistics	_	_	NNS	_	_	_	_	_
3	were	_	_	VBD	_	_	_	_	_
4	employed	_	_	VBN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	these	_	_	DT	_	_	_	_	_
7	studies	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	it	_	_	PRP	_	_	_	_	_
10	would	_	_	MD	_	_	_	_	_
11	be	_	_	VB	_	_	_	_	_
12	very	_	_	RB	_	_	_	_	_
13	difficult	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	extract	_	_	VB	_	_	_	_	_
16	learning	_	_	NN	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	nature	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	potential	_	_	JJ	_	_	_	_	_
24	benefits	_	_	NNS	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	employing	_	_	VBG	_	_	_	_	_
27	different	_	_	JJ	_	_	_	_	_
28	design	_	_	NN	_	_	_	_	_
29	approaches	_	_	NNS	_	_	_	_	_
30	since	_	_	IN	_	_	_	_	_
31	these	_	_	DT	_	_	_	_	_
32	investigations	_	_	NNS	_	_	_	_	_
33	focused	_	_	VBN	_	_	_	_	_
34	on	_	_	IN	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	empirical	_	_	JJ	_	_	_	_	_
37	aspects	_	_	NNS	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	study	_	_	NN	_	_	_	_	_
41	rather	_	_	RB	_	_	_	_	_
42	than	_	_	IN	_	_	_	_	_
43	providing	_	_	VBG	_	_	_	_	_
44	an	_	_	DT	_	_	_	_	_
45	in-depth	_	_	JJ	_	_	_	_	_
46	evaluation	_	_	NN	_	_	_	_	_
47	of	_	_	IN	_	_	_	_	_
48	the	_	_	DT	_	_	_	_	_
49	statistical	_	_	JJ	_	_	_	_	_
50	tools	_	_	NNS	_	_	_	_	_
51	employed	_	_	VBN	_	_	_	_	_
52	.	_	_	.	_	_	_	_	_


1	Consequently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	they	_	_	PRP	_	_	_	_	_
4	fail	_	_	VBP	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	compare	_	_	VB	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	contrast	_	_	VB	_	_	_	_	_
9	different	_	_	JJ	_	_	_	_	_
10	methods	_	_	NNS	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	provide	_	_	VB	_	_	_	_	_
13	reasoning	_	_	NN	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	selection	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	certain	_	_	JJ	_	_	_	_	_
19	models	_	_	NNS	_	_	_	_	_
20	over	_	_	IN	_	_	_	_	_
21	others	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	or	_	_	CC	_	_	_	_	_
24	point	_	_	NN	_	_	_	_	_
25	towards	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	utilization	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	favorable	_	_	JJ	_	_	_	_	_
30	statistical	_	_	JJ	_	_	_	_	_
31	designs	_	_	NNS	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	which	_	_	WDT	_	_	_	_	_
34	could	_	_	MD	_	_	_	_	_
35	prove	_	_	VB	_	_	_	_	_
36	invaluable	_	_	JJ	_	_	_	_	_
37	to	_	_	TO	_	_	_	_	_
38	attain	_	_	VB	_	_	_	_	_
39	systematic	_	_	JJ	_	_	_	_	_
40	medium	_	_	JJ	_	_	_	_	_
41	development	_	_	NN	_	_	_	_	_
42	strategies	_	_	NNS	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	2.2	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Metabolic	_	_	JJ	_	_	_	_	_
2	Profiling	_	_	NN	_	_	_	_	_


1	Another	_	_	DT	_	_	_	_	_
2	method	_	_	NN	_	_	_	_	_
3	widely	_	_	RB	_	_	_	_	_
4	used	_	_	VBN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	industry	_	_	NN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	understand	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	impact	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	amino	_	_	JJ	_	_	_	_	_
14	acid	_	_	NN	_	_	_	_	_
15	composition	_	_	NN	_	_	_	_	_
16	on	_	_	IN	_	_	_	_	_
17	mAb	_	_	NN	_	_	_	_	_
18	production	_	_	NN	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	exo-	_	_	JJ	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	endo-metabolic	_	_	JJ	_	_	_	_	_
23	profiling	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Such	_	_	JJ	_	_	_	_	_
2	methods	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	purely	_	_	RB	_	_	_	_	_
5	empirical	_	_	JJ	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	mainly	_	_	RB	_	_	_	_	_
9	utilized	_	_	VBN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	improve	_	_	VB	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	established	_	_	VBN	_	_	_	_	_
14	platform	_	_	NN	_	_	_	_	_
15	process	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	by	_	_	IN	_	_	_	_	_
18	suggesting	_	_	VBG	_	_	_	_	_
19	specific	_	_	JJ	_	_	_	_	_
20	nutrients	_	_	NNS	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	be	_	_	VB	_	_	_	_	_
23	added	_	_	VBN	_	_	_	_	_
24	during	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	course	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	cultivation	_	_	NN	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	for	_	_	IN	_	_	_	_	_
32	example	_	_	NN	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	rather	_	_	RB	_	_	_	_	_
35	than	_	_	IN	_	_	_	_	_
36	to	_	_	TO	_	_	_	_	_
37	conduct	_	_	VB	_	_	_	_	_
38	a	_	_	DT	_	_	_	_	_
39	broad	_	_	JJ	_	_	_	_	_
40	de	_	_	NNP	_	_	_	_	_
41	novo	_	_	NN	_	_	_	_	_
42	exploration	_	_	NN	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_

